Alkannin Attenuates Amyloid β Aggregation and Alzheimer’s Disease Pathology
Molecular Pharmacology · 2023
DOI: 10.1124/molpharm.121.000468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2023. Verfasst von Toru Hosoi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, Sanyo Onoda, Japan (T.H.); Department of Pharma…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, Sanyo Onoda, Japan (T.H.); Department of Pharmacotherapy, Graduate School of Biomedical and Health Sciences, Hiroshim…
Zitieren
APA
Hosoi, T., Yazawa, K., Imada, M., Tawara, A., Tohda, C., Nomura, Y., & Ozawa, K. (2023). Alkannin Attenuates Amyloid β Aggregation and Alzheimer’s Disease Pathology. Molecular Pharmacology. https://doi.org/10.1124/molpharm.121.000468
Vancouver
Hosoi T, Yazawa K, Imada M, Tawara A, Tohda C, Nomura Y, et al. Alkannin Attenuates Amyloid β Aggregation and Alzheimer’s Disease Pathology. Molecular Pharmacology. 2023. doi:10.1124/molpharm.121.000468
BibTeX
@article{Hosoi2023,
author = {Hosoi, Toru and Yazawa, Kyosuke and Imada, Michihiro and Tawara, Akari and Tohda, Chihiro and Nomura, Yasuyuki and Ozawa, Koichiro},
title = {Alkannin Attenuates Amyloid β Aggregation and Alzheimer’s Disease Pathology},
journal = {Molecular Pharmacology},
year = {2023},
doi = {10.1124/molpharm.121.000468}
}
EUVIMED